Trial Profile
Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Mar 2011
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Dyspepsia; Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms RESPONSE
- Sponsors AstraZeneca
- 27 Oct 2009 Secondary endpoint results presented at the 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
- 03 Feb 2009 New trial record